生命科学资讯

The Cooper Companies under activist pressure to split—in different ways

Moderna's reshaping rolls on with 3 more pipeline purges

How a 'healthy exchange of ideas' with RFK Jr. kick-started FDA's gene therapy push

GE HealthCare to acquire imaging software provider Intelerad for $2.3B

Fierce Biotech Layoff Tracker 2025: Applied Tx lays off 46% of staff; Ensoma makes cuts

In letter to Makary, biotech CEOs push for FDA stability and say volatility threatens US innovation

Contineum's J&J-partnered MS drug fails to improve vision in phase 2

FDA says it's hiring more than 1,000 new staffers, launches new comms program for review process

GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement

Nurix trims workforce as pivotal trial for lead BTK degrader kicks off

Roche inks $200M-plus licensing pact for Freenome's cancer screening blood tests

Chutes & Ladders—Gilead abruptly parts ways with general counsel

CDC instructs researchers to end all monkey studies by year-end: Science

Versant's Dayra dawns with $50M Biogen pact, oral macrocyclic peptide mission

J&J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2

Abbott to replace certain FreeStyle Libre 3 CGMs after incorrect readings and death reports

Gilead hatches $400M biobucks deal for Swedish biotech’s TREX1 cancer program

Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease

'People are getting used to it': Global uncertainties can't dampen upbeat Jefferies conference

Bayer's asundexian cuts stroke risk in phase 3, reviving hopes for FXIa class